COMPASS: Cardiovascular consequences of discontinuing low-dose rivaroxaban in people with chronic coronary or peripheral artery disease
BMJ Heart
GR Dagenais, L Dyal, JJ Bosch, DP Leong, V Aboyans, SD Berkowitz, DL Bhatt, SJ Connolly, KAA Fx, E Muehlhofer, JL Probstfield, P Widimsky, BR Winkelmann, S Yusuf, JW Eikelboom
May 2021
